Low-BMI, sub-160 lb, older, or side-effect-sensitive non-micro users often start at 0.3 mg, with the band still building to at least 1 mg before response is judged
A potentially novel target to treat obesity and type 2 diabetes is nicotinamide-N-methyltransferase (NNMT), a cytosolic enzyme with newly identified roles in cellular metabolism and energy homeostasis
Zhu, X., Huang, C., & Peng, B
Its undeniable that we all wish to have clear and silky skin overnight, but truthfully, miracles take time
Glutathione deficiency and oxidative stress in aging: metabolic mechanism and targeted intervention
Docosahexaenoic acid partially ameliorates deficits in social behavior and ultrasonic vocalizations caused by prenatal ethanol exposure